Show Summary Details
Page of

Psychopharmacologic Interventions in Preschool Children with ADHD: General Considerations and Evidence 

Psychopharmacologic Interventions in Preschool Children with ADHD: General Considerations and Evidence
Chapter:
Psychopharmacologic Interventions in Preschool Children with ADHD: General Considerations and Evidence
Author(s):

Jaswinder K. Ghuman

and Harinder S. Ghuman

DOI:
10.1093/med/9780199948925.003.0007
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 May 2019

Treating clinicians face several challenges and dilemmas when considering pharmacologic treatment for ADHD in preschool children. This chapter reviews currently available evidence for psychopharmacologic interventions for ADHD in preschool children. Medication prescribing trends and practice guidelines for treating ADHD in preschool children are presented followed by a detailed discussion regarding the controversies, dilemmas, and challenges in prescribing medications to preschoolers. The role of the FDA and the impact of the Modernization Act in promoting meaningful pharmacologic research in preschool children are discussed. The second half of the chapter is devoted to review and discussion of studies of various pharmacologic agents used in the treatment of ADHD in preschool children. Findings of the Preschool ADHD Treatment Study (PATS) are described in detail. The chapter concludes with a discussion of special pharmacologic treatment considerations in preschoolers with developmental disorders and pill-swallowing difficulties.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.